All News
ACR 2018 - Day 1 Report
RheumNow is in Chicago covering the ACR annual meeting. Here are the highlights from Sunday (day one). Be sure to check our complete coverage, including articles, video reports and tweets, at acr18.rheumnow.com.
Read ArticleGout and the Social Determinants of Health
During a fascinating gout session on October 21, Hyon Choi presented an important paper (abstract 874) which used data from the Health Professionals Follow-up Study to try to understand the rapid increase in the incidence of gout in recent decades.
Read ArticleBecause It's Rare Doesn’t Mean It Doesn’t Exist: A Tribute to Relapsing Polychondritis
During medical training, we were taught about rare diseases that are unlikely to be encountered, but there is a reason why our professors even mention these diseases. It is not just for our board exams; the lectures are for us to recognize the features of the disease when the rare patient comes across our exam table.
Read ArticleHigh Dose Flu Vaccine for Patients Younger Than 65?
We are diving head first into flu season and we need to prepare ourselves. Last year we now know that 80,000 Americans died from influenza.
Read ArticleThe Great Debate: Plaquenil - Choosing Safety over Efficacy?
RheumNow Week in Review – ACR Preview Edition (10.19.18)
Dr. Jack Cush summarizes the news and reports from RheumNow.Com this past week and previews RheumNow activities at the upcoming ACR 2018 meeting in Chicago.
Read ArticleRheumNow Week in Review – Four Fingers are Best (10.12.18)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. New info on scleroderma-SLE overlap, nailfold capillaroscopy, Women with SpA, acute gout management and lupus patient in pain who visit the ED.
Read ArticleCarpal Tunnel Syndrome - a Leading Cause of Work Related Disability
MMWR reports that workers’ compensation claims for carpal tunnel syndrome (CTS) in California during 2007–2014 were 6.3 per 10,000 full-time equivalent workers, with female workers and workers in industries that manufacture apparel, process food, and perform administrative work being at highest r
Read ArticleRheumNow Week in Review – Vitamin D Falls Again (10.4.18)
Dr. Jack Cush reviews the news from the past week on RheumNow.com.
Read ArticleRheumNow Week in Review – I Wanna New Drug (9.28.18)
Dr. Jack Cush reviews the news from the past week on RheumNow.com, including news on inappropriate opioids, pre-clinical RA treatment, DMARDs in Gout, the decline of arthroscopy, and a pain in the mouth.
Read ArticleVenous Thromboembolism Increased with Rheumatoid Arthritis, Not with TNF Inhibition
Venous thromboembolism (VTE) is a common adverse event throughout medicine and includes both pulmonary embolism (PE) and deep vein thrombosis (DVT). The cost of diagnosing a thromboembolic event is approximately $4000 - $5550, while the annual cost of treating one case of VTE is betwe
Read ArticleCDC: 2017 Record Number of Influenza Deaths
The CDC reports that in 2017, influenza killed and hospitalized more people in the United States than any other year in the last few decades.
Read ArticleRheumNow Week in Review – RheumNow Live Meeting Announcement (9.21.18)
Dr. Jack Cush reviews the news and updates from the past week on RheumNow.
Read ArticleMaastricht Study Links Dairy Intake to Osteoarthritis
The Maastricht study explored the potential association between dairy consumption and knee osteoarthritis (OA), and found that higher intake of full-fat dairy and Dutch cheese - but not milk - was significantly associated with the lower risk of knee OA.
Read ArticleFDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized
In response to the growing opioid crisis, the US Food and Drug Administration has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), designed to reduce the risk of abuse, misuse, addiction, overdose, and deaths due to prescription opioid analgesics.
Read ArticleNew Classification of Idiopathic Inflammatory Myopathies
Using an observational cohort analysis of patients in the French myositis network, researchers have proposed a new classification of idiopathic inflammatory myopathies (IIM) with four subgroups: dermatomyositis, inclusion body myositis, immune-mediated necrotizing myopathy, and antisynthetas
Read ArticleRheumNow Week in Review – Gout and Hearing Loss, Huh? (9.14.18)
Dr. Jack Cush's weekly review of the news on RheumNow.com.
Read ArticlePhysician Burnout May Jeopardize Patient Safety
A metanalysis of studies and over 42,000 physician shows that MD burnout is associated with 2-fold increased in unsafe care, unprofessional behaviors, and low patient satisfaction.
The primary outcomes were the quantitative associations between burnout and patient safety, professionalism, and patient satisfaction.
RheumNow Week in Review – Medical School Advice (9.7.18)
Dr. Jack Cush reviews news and journal articles from the past week on RheumNow.com.
Read ArticleACR Releases State-by-State Rheumatic Disease Report Card
The American College of Rheumatology (ACR) today released the Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America, a first-of-its-kind report that evaluates just how difficult it can be to live well with a rheumatic disease in the United States.
Read Article


